UTG-4

N/A

Report date: 2026/04/03 20:03:44
NME

Base Information

Drug NameUTG-4
Drug Alias NameN/A
ClassificationSmall molecules > Synthetic peptide > Circular polypeptide
Mechanisms of ActionGlucagon-like peptide 1 receptor agonistsGlucose-Dependent Insulinotropic Polypeptide Receptor agonistsGlucagon receptor agonists
TargetsGlucagon-like peptide 1 receptorGlucose-Dependent Insulinotropic Polypeptide ReceptorGlucagon receptor
Therapy Area/IndicationsObesityAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesGuangzhou University Of Chinese Medicine
China Registration ClassN/A

Develop Information

Active CompaniesGuangzhou University Of Chinese Medicine
Inactive CompaniesN/A
Active IndicationsObesityAtherosclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A